Ian O Ellis

Ian O Ellis

UNVERIFIED PROFILE

Are you Ian O Ellis?   Register this Author

Register author
Ian O Ellis

Ian O Ellis

Publications by authors named "Ian O Ellis"

Are you Ian O Ellis?   Register this Author

100Publications

2353Reads

46Profile Views

The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts.

Mod Pathol 2019 Jul 13;32(7):967-976. Epub 2019 Feb 13.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0209-9DOI Listing
July 2019

Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution.

Breast J 2019 Jul 18. Epub 2019 Jul 18.

Division of Cancer and Stem Cells, Nottingham Breast Cancer Research Centre, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13425DOI Listing
July 2019

The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ.

Histopathology 2019 Jun 14;74(7):1025-1035. Epub 2019 Apr 14.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Notts, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13835DOI Listing
June 2019

Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study.

Mod Pathol 2019 Jun 7. Epub 2019 Jun 7.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0296-7DOI Listing
June 2019

Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ.

Mod Pathol 2019 Jun 7. Epub 2019 Jun 7.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0286-9DOI Listing
June 2019

Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles.

Artif Intell Med 2019 Jun 15;97:27-37. Epub 2019 May 15.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.artmed.2019.05.002DOI Listing
June 2019

Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.

Mod Pathol 2019 May 14;32(5):639-649. Epub 2018 Nov 14.

Department of Histopathology, Nottingham Breast Cancer Research Center, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0180-xDOI Listing
May 2019

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05111-wDOI Listing
May 2019

The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution.

Br J Cancer 2019 May 8;120(11):1075-1082. Epub 2019 May 8.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0436-3DOI Listing
May 2019

Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.

Breast Cancer Res Treat 2019 Apr 15;174(2):387-399. Epub 2018 Dec 15.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05085-9DOI Listing
April 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-5060-zDOI Listing
February 2019

Connexin 43 is an independent predictor of patient outcome in breast cancer patients.

Breast Cancer Res Treat 2019 Feb 24;174(1):93-102. Epub 2018 Nov 24.

Cancer Immunology Group, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-5063-9
Publisher Site
http://dx.doi.org/10.1007/s10549-018-5063-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418069PMC
February 2019

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4978-5
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4978-5DOI Listing
January 2019

Liver Kinase B1-A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women.

Cancers (Basel) 2019 Jan 28;11(2). Epub 2019 Jan 28.

Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham, DE22 3DT Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/11/2/149
Publisher Site
http://dx.doi.org/10.3390/cancers11020149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406422PMC
January 2019

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13695DOI Listing
December 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0086-7DOI Listing
December 2018

Impact of breast cancer grade discordance on prediction of outcome.

Histopathology 2018 Dec 19;73(6):904-915. Epub 2018 Sep 19.

Department of Histopathology, South Austin Hospital, Austin, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13709DOI Listing
December 2018

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS).

Br J Cancer 2018 Dec 9;119(12):1518-1526. Epub 2018 Nov 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0337-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288166PMC
December 2018

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Arch Pathol Lab Med 2018 11 30;142(11):1364-1382. Epub 2018 May 30.

Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; Lisa M. McShane, National Cancer Institute, Bethesda, Maryland; M. Elizabeth Hale Hammond, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City; Kimberly H. Allison, Stanford University School of Medicine, Stanford, California; Patrick Fitzgibbons, St Jude Medical Center, Fullerton, California; Michael F. Press, University of Southern California, Los Angeles; Brittany E. Harvey and Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, Virginia; John M.S. Bartlett, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Wedad Hanna, Sunnybrook Health Sciences Centre and Women's College Hospital, Toronto, Ontario, Canada; Michael Bilous, Western Sydney University and Australian Clinical Laboratories, Sydney, Australia; Ian O. Ellis, The University of Nottingham, Nottingham, United Kingdom; Mitchell Dowsett, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Robert B. Jenkins, Mayo Clinic, Rochester, Minnesota; Patricia A. Spears, Cancer Information and Support Network, Raleigh, North Carolina; Gail H. Vance, Indiana University School of Medicine, Indianapolis; and Giuseppe Viale, University of Milan and Istituto Europeo di Oncologia, Milan, Italy.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-090
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0902-SADOI Listing
November 2018

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0092-9DOI Listing
November 2018

Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.

Pathobiology 2018 10;85(1-2):23-34. Epub 2018 Feb 10.

Department of Histopathology, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/477851
Publisher Site
http://dx.doi.org/10.1159/000477851DOI Listing
October 2018

Diagnostic concordance of reporting lymphovascular invasion in breast cancer.

J Clin Pathol 2018 Sep 29;71(9):802-805. Epub 2018 Mar 29.

Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204981DOI Listing
September 2018

Breast cancer histologic grading using digital microscopy: concordance and outcome association.

J Clin Pathol 2018 Aug 13;71(8):680-686. Epub 2018 Mar 13.

Department of Histopathology, South Austin Hospital, Austin, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204979DOI Listing
August 2018

Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.

Mod Pathol 2018 08 20;31(8):1226-1236. Epub 2018 Mar 20.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0040-8DOI Listing
August 2018

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Breast Cancer Res 2018 08 30;20(1):98. Epub 2018 Aug 30.

Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3XF, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0999-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117898PMC
August 2018

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

J Clin Oncol 2018 Jul 30;36(20):2105-2122. Epub 2018 May 30.

Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth Hale Hammond, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City, UT; Kimberly H. Allison, Stanford University School of Medicine, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Brittany E. Harvey and Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Centre and Women's College Hospital, Toronto, Ontario, Canada; Michael Bilous, Western Sydney University and Australian Clinical Laboratories, Sydney, New South Wales, Australia; Ian O. Ellis, The University of Nottingham, Nottingham; Mitchell Dowsett, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Patricia A. Spears, Cancer Information and Support Network, Raleigh, NC; Gail H. Vance, Indiana University School of Medicine, Indianapolis, IN; and Giuseppe Viale, University of Milan and Istituto Europeo di Oncologia, Milan, Italy.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.8738
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.8738DOI Listing
July 2018

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.

Breast Cancer Res Treat 2018 Jun 2;169(2):277-286. Epub 2018 Feb 2.

Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham University Hospitals, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4683-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945733PMC
June 2018

Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients.

Oncotarget 2018 May 25;9(40):25946-25956. Epub 2018 May 25.

Translational and Radiation Biology Research Group, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995224PMC
May 2018

IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients.

Cancer Immunol Immunother 2018 Apr 18;67(4):537-549. Epub 2017 Dec 18.

Division of Cancer and Stem Cells, Academic Clinical Oncology, School of Medicine, University of Nottingham, Nottingham University Hospitals NHS Trust, City Hospital Campus, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860102PMC
April 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0038-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931111PMC
April 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0041-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931067PMC
April 2018

High nuclear MSK1 is associated with longer survival in breast cancer patients.

J Cancer Res Clin Oncol 2018 Mar 11;144(3):509-517. Epub 2018 Jan 11.

University of Nottingham, Division of Cancer and Stem Cells, Department of Clinical Oncology, School of Medicine, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2579-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816103PMC
March 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0946-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851PMC
March 2018

Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.

Histopathology 2018 Jan 17;72(2):183-190. Epub 2017 Oct 17.

Academic Pathology, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13334DOI Listing
January 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/bjc.2017.387
Publisher Site
http://dx.doi.org/10.1038/bjc.2017.387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785743PMC
January 2018

Diagnostic challenges in papillary lesions of the breast.

Pathology 2018 Jan 26;50(1):100-110. Epub 2017 Nov 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313025173051
Publisher Site
http://dx.doi.org/10.1016/j.pathol.2017.10.005DOI Listing
January 2018

The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Am J Pathol 2017 Oct 20;187(10):2139-2151. Epub 2017 Jul 20.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.03.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809519PMC
October 2017

Reply to Rosen.

Mod Pathol 2017 10;30(10):1505-1506

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.70DOI Listing
October 2017

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13217DOI Listing
August 2017

Solid Papillary Breast Carcinomas Resembling the Tall Cell Variant of Papillary Thyroid Neoplasms: A Unique Invasive Tumor With Indolent Behavior.

Am J Surg Pathol 2017 Jul;41(7):887-895

*Department of Biomedical and Neuromotor Sciences, Section of Pathology "M. Malpighi," University of Bologna, Bologna ∥Department of Pathology, CDI, Milano, Italy †Pathology Unit, Laboratories Dr. Macedo Dias, Porto, Portugal ‡Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary §Department of Histopathology, Nottingham City Hospital, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000853DOI Listing
July 2017

Phenotypic characterisation of breast cancer: the role of CDC42.

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4267-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487723PMC
July 2017

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.

Breast Cancer Res Treat 2017 Jul 6;164(2):341-348. Epub 2017 May 6.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4270-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487701PMC
July 2017

Immunoprofile of metaplastic carcinomas of the breast.

Histopathology 2017 May 2;70(6):975-985. Epub 2017 Mar 2.

Department of Histopathology, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13159
Publisher Site
http://dx.doi.org/10.1111/his.13159DOI Listing
May 2017

Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?

Histopathology 2017 Apr 20;70(5):681-692. Epub 2016 Dec 20.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13116
Publisher Site
http://dx.doi.org/10.1111/his.13116DOI Listing
April 2017

Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers.

Cancer Immunol Res 2017 04 2;5(4):292-299. Epub 2017 Mar 2.

Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0195DOI Listing
April 2017

Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.

J Pathol Clin Res 2017 Apr 30;3(2):105-114. Epub 2017 Mar 30.

Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402178PMC
April 2017

Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.

Histopathology 2017 Mar 28;70(4):622-631. Epub 2016 Dec 28.

Departments of Histopathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13108DOI Listing
March 2017

Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.

Apoptosis 2017 03;22(3):357-368

Division of Cancer and Stem Cells, Department of Clinical Oncology, School of Medicine, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-016-1323-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306438PMC
March 2017

Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.

Histopathology 2017 Mar 28;70(4):632-642. Epub 2016 Dec 28.

Department of Histopathology, Nottingham City Hospital, Nottingham B, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13117DOI Listing
March 2017

Further evidence to support bimodality of oestrogen receptor expression in breast cancer.

Histopathology 2017 Feb 28;70(3):456-465. Epub 2016 Nov 28.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13089DOI Listing
February 2017

Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.

J Clin Pathol 2017 Jan 12;70(1):51-57. Epub 2016 Jul 12.

Department of Histopathology, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2016-203800DOI Listing
January 2017

Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.

Mol Cancer Ther 2017 01 11;16(1):239-250. Epub 2016 Nov 11.

Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222686PMC
January 2017

Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.

Pathol Res Pract 2017 Jan 25;213(1):27-33. Epub 2016 Oct 25.

Division of Cancer and Stem Cells, School of Medicine, Nottingham University Hospitals and University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2016.10.005DOI Listing
January 2017

Papillary carcinoma of the breast: diagnostic agreement and management implications.

Histopathology 2016 Nov 1;69(5):862-870. Epub 2016 Aug 1.

Department of Histopathology, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13009DOI Listing
November 2016

Clinicopathologic Characteristics of Solid Papillary Carcinoma of the Breast.

Am J Surg Pathol 2016 10;40(10):1334-42

*Department of Pathology, Singapore General Hospital, Singapore †Department of Histopathology, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000702DOI Listing
October 2016

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.

Breast Cancer Res Treat 2016 Oct 3;159(3):457-67. Epub 2016 Sep 3.

Division of Cancer and Stem Cells, Department of Histopathology, School of Medicine, Nottingham City Hospital, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3967-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021722PMC
October 2016

Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.

Breast Cancer Res Treat 2016 Sep 11;159(2):215-27. Epub 2016 Aug 11.

Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3934-5DOI Listing
September 2016

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.

Breast Cancer Res Treat 2016 08 27;159(1):41-53. Epub 2016 Jul 27.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3915-8DOI Listing
August 2016

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Breast Cancer Res Treat 2016 Feb 23;156(1):9-20. Epub 2016 Feb 23.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3709-zDOI Listing
February 2016

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

J Pathol Clin Res 2016 Jan 15;2(1):32-40. Epub 2016 Jan 15.

Division of Cancer and Stem CellsBreast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City HospitalHucknall RoadNottinghamNG5 1PB; Cellular Pathology, Nottingham University Hospitals NHS TrustHucknall RoadNottinghamNG5 1PB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858129PMC
January 2016